NeurAxis (NRXS) Competitors $2.40 -0.01 (-0.41%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.42 +0.02 (+0.63%) As of 07/11/2025 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRXS vs. SRTS, GUTS, MDAI, SURG, NVNO, NSPR, CTSO, EDAP, HYPR, and ICCMShould you be buying NeurAxis stock or one of its competitors? The main competitors of NeurAxis include Sensus Healthcare (SRTS), Fractyl Health (GUTS), Spectral AI (MDAI), SurgePays (SURG), enVVeno Medical (NVNO), InspireMD (NSPR), Cytosorbents (CTSO), Edap Tms (EDAP), Hyperfine (HYPR), and IceCure Medical (ICCM). These companies are all part of the "medical equipment" industry. NeurAxis vs. Its Competitors Sensus Healthcare Fractyl Health Spectral AI SurgePays enVVeno Medical InspireMD Cytosorbents Edap Tms Hyperfine IceCure Medical Sensus Healthcare (NASDAQ:SRTS) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends. Do analysts prefer SRTS or NRXS? Sensus Healthcare currently has a consensus price target of $11.67, suggesting a potential upside of 180.45%. NeurAxis has a consensus price target of $7.00, suggesting a potential upside of 191.67%. Given NeurAxis' higher possible upside, analysts clearly believe NeurAxis is more favorable than Sensus Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00NeurAxis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation and earnings, SRTS or NRXS? Sensus Healthcare has higher revenue and earnings than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensus Healthcare$41.81M1.64$6.65M$0.1041.60NeurAxis$2.93M5.90-$14.63M-$1.19-2.02 Do institutionals & insiders hold more shares of SRTS or NRXS? 25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 11.8% of NeurAxis shares are held by institutional investors. 8.9% of Sensus Healthcare shares are held by insiders. Comparatively, 26.4% of NeurAxis shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is SRTS or NRXS more profitable? Sensus Healthcare has a net margin of 4.56% compared to NeurAxis' net margin of -492.76%. Sensus Healthcare's return on equity of 3.34% beat NeurAxis' return on equity.Company Net Margins Return on Equity Return on Assets Sensus Healthcare4.56% 3.34% 3.00% NeurAxis -492.76%N/A -641.25% Does the media prefer SRTS or NRXS? In the previous week, NeurAxis had 1 more articles in the media than Sensus Healthcare. MarketBeat recorded 2 mentions for NeurAxis and 1 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 1.89 beat NeurAxis' score of 0.84 indicating that Sensus Healthcare is being referred to more favorably in the media. Company Overall Sentiment Sensus Healthcare Very Positive NeurAxis Positive Which has more risk and volatility, SRTS or NRXS? Sensus Healthcare has a beta of 1.29, meaning that its stock price is 29% more volatile than the S&P 500. Comparatively, NeurAxis has a beta of 3.09, meaning that its stock price is 209% more volatile than the S&P 500. SummarySensus Healthcare beats NeurAxis on 10 of the 15 factors compared between the two stocks. Get NeurAxis News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NRXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRXS vs. The Competition Export to ExcelMetricNeurAxisElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.32M$33.52M$5.60B$9.11BDividend YieldN/AN/A5.24%4.02%P/E Ratio-1.303.2327.9620.25Price / Sales5.90195.34430.5799.61Price / CashN/A41.3637.4658.16Price / Book-8.892.058.045.49Net Income-$14.63M-$25.54M$3.18B$250.27M7 Day Performance-6.25%8.18%3.63%4.75%1 Month Performance4.35%45.42%4.04%7.64%1 Year Performance-18.37%135.80%29.56%16.34% NeurAxis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRXSNeurAxis3.3123 of 5 stars$2.40-0.4%$7.00+191.7%-14.0%$17.32M$2.93M-1.3019Gap UpSRTSSensus Healthcare1.3118 of 5 stars$4.64+1.1%$11.67+151.4%-26.9%$76.20M$41.81M46.3540Positive NewsGUTSFractyl Health2.2689 of 5 stars$1.52-1.6%$11.00+626.1%-67.5%$74.21M$90K-0.82102MDAISpectral AI3.6592 of 5 stars$2.79+2.6%$4.75+70.3%+57.1%$70.52M$29.58M-5.1683Gap UpSURGSurgePays3.2142 of 5 stars$3.41+3.4%$9.00+163.9%+5.0%$69.89M$40.03M-1.2340News CoverageNVNOenVVeno Medical0.6327 of 5 stars$4.01+1.9%N/A-29.7%$69.81MN/A-3.3730NSPRInspireMD2.9878 of 5 stars$2.23+0.2%$4.50+102.2%-4.1%$68.01M$7.03M-2.9650News CoverageCTSOCytosorbents1.6544 of 5 stars$1.07+3.4%$5.50+416.4%+8.8%$66.68M$35.33M-3.80220EDAPEdap Tms3.0906 of 5 stars$1.62+2.9%$8.50+426.3%-69.1%$60.35M$62.77M-2.60230HYPRHyperfine3.1751 of 5 stars$0.78+1.7%$1.06+36.2%-26.1%$60.16M$12.89M-1.43190Positive NewsICCMIceCure Medical2.3472 of 5 stars$1.08+2.8%$2.50+131.7%+40.8%$59.11M$3.27M-3.8060News CoverageAnalyst Downgrade Related Companies and Tools Related Companies Sensus Healthcare Alternatives Fractyl Health Alternatives Spectral AI Alternatives SurgePays Alternatives enVVeno Medical Alternatives InspireMD Alternatives Cytosorbents Alternatives Edap Tms Alternatives Hyperfine Alternatives IceCure Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NRXS) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
